UB Paderborn / Katalog / Suche / in CDI

Mitochondrial STAT3 Supports Ras-Dependent Oncogenic Transformation

Science (American Association for the Advancement of Science), 2009-06, Vol.324 (5935), p.1713-1716

2009

Link zum Volltext

Verfügbarkeit prüfen

Over-expression of DSCR1 protects against post-ischemic neuronal injury

PloS one, 2012-10, Vol.7 (10), p.e47841-e47841

2012

Link zum Volltext

Verfügbarkeit prüfen

SP-014 - 18F labelled albumin binding synthons enabling PET imaging and enhanced target accumulation of biomolecules

Nuclear medicine and biology, 2021-05, Vol.96-97, p.S41-S42

2021

Link zum Volltext

Verfügbarkeit prüfen

18F labelled albumin binding synthons enabling PET imaging and enhanced target accumulation of biomolecules

Nuclear medicine and biology, 2021-05, Vol.96-97, p.S41-S42

2021

Link zum Volltext

Verfügbarkeit prüfen

Mitochondrial STAT3 Supports RasDependent Oncogenic Transformation

Science (American Association for the Advancement of Science), 2009-06, Vol.324 (5935), p.1713-1716

2009

Link zum Volltext

Verfügbarkeit prüfen

SSP-05 - Next generation therapeutic radiopharmaceuticals targeting cholecystokinin-2 receptor positive cancers

Nuclear medicine and biology, 2021-05, Vol.96-97, p.S16-S16

2021

Link zum Volltext

Verfügbarkeit prüfen

Next generation therapeutic radiopharmaceuticals targeting cholecystokinin-2 receptor positive cancers

Nuclear medicine and biology, 2021-05, Vol.96-97, p.S16

2021

Link zum Volltext

Verfügbarkeit prüfen

The Next Generation of Tumour Homing Peptides: Foldamers at the Forefront of Precise Cancer Theranostics

Nuclear medicine and biology, 2023-11, Vol.126-127, p.108794, Article 108794

2023

Link zum Volltext

Verfügbarkeit prüfen

SP-128 - Structure-activity relationship study of peptide Gastramide-01 (GA-01), a potent binder of cholecystokinin-2 (CCK-2) receptor and theranostic candidate

Nuclear medicine and biology, 2021-05, Vol.96-97, p.S107-S107

2021

Link zum Volltext

Verfügbarkeit prüfen

Foldamers afford improved theranostics targeting cholecystokinin-2 receptor positive cancers

Nuclear medicine and biology, 2021-05, Vol.96-97, p.S16-S17

2021

Link zum Volltext

Verfügbarkeit prüfen

Structure-activity relationship study of peptide Gastramide-01 (GA-01), a potent binder of cholecystokinin-2 (CCK-2) receptor and theranostic candidate

Nuclear medicine and biology, 2021-05, Vol.96-97, p.S107

2021

Link zum Volltext

Verfügbarkeit prüfen

SSP-06 - Foldamers afford improved theranostics targeting cholecystokinin-2 receptor positive cancers

Nuclear medicine and biology, 2021-05, Vol.96-97, p.S16-S17

2021

Link zum Volltext

Verfügbarkeit prüfen

Indirect Lung Absorbed Dose Verification by 90 Y PET/CT and Complete Lung Protection by Hepatic Vein Balloon Occlusion: Proof of Concept

Journal of nuclear medicine technology, 2022-09, Vol.50 (3), p.240-243

2022

Link zum Volltext

Verfügbarkeit prüfen

Development of Highly Potent Clinical Candidates for Theranostic Applications against Cholecystokinin‑2 Receptor Positive Cancers

Journal of medicinal chemistry, 2023-08, Vol.66 (15), p.10289-10303

2023

Link zum Volltext

Verfügbarkeit prüfen

A New Turn in Peptide-Based Imaging Agents: Foldamers Afford Improved Theranostics Targeting Cholecystokinin‑2 Receptor-Positive Cancer

Journal of medicinal chemistry, 2021-04, Vol.64 (8), p.4841-4856

2021

Link zum Volltext

Verfügbarkeit prüfen

90Y PET for Qualitative and Quantitative Assessment of Residual Activity in Delivery Apparatus After Radioembolization

Journal of nuclear medicine technology, 2021-06, Vol.49 (2), p.178-179

2021

Link zum Volltext

Verfügbarkeit prüfen

90 Y PET for Qualitative and Quantitative Assessment of Residual Activity in Delivery Apparatus After Radioembolization

Journal of nuclear medicine technology, 2021-06, Vol.49 (2), p.178-179

2021

Link zum Volltext

Verfügbarkeit prüfen

Precision peptide theranostics: developing N - to C -terminus optimized theranostics targeting cholecystokinin-2 receptor

Theranostics, 2024-01, Vol.14 (5), p.1815-1828

2024

Link zum Volltext

Verfügbarkeit prüfen

Indirect Lung Absorbed Dose Verification by 90Y PET/CT and Complete Lung Protection by Hepatic Vein Balloon Occlusion: Proof of Concept

Journal of nuclear medicine technology, 2022-09, Vol.50 (3), p.240-243

2022

Link zum Volltext

Verfügbarkeit prüfen

Indirect lung absorbed dose verification by yttrium-90 PET/CT and complete lung protection by hepatic vein balloon occlusion: proof-of-concept

Journal of nuclear medicine technology, 2022-04

2022

Link zum Volltext

Verfügbarkeit prüfen

Investigation of Fluorine-18 Labelled Peptides for Binding to Cholecystokinin-2 Receptors with High Affinity

International journal of peptide research and therapeutics, 2022, Vol.28 (1), Article 6

2022

Link zum Volltext

Verfügbarkeit prüfen

Over-expression of RCAN1 causes Down syndrome-like hippocampal deficits that alter learning and memory

Human molecular genetics, 2012-07, Vol.21 (13), p.3025-3041

2012

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Investigation of Fluorine-18 Labelled Peptides for Binding to Cholecystokinin-2 Receptors with High Affinity

International journal of peptide research and therapeutics, 2022, Vol.28 (1), Article 45

2022

Link zum Volltext

Verfügbarkeit prüfen

Yttrium-90 positron emission tomography for qualitative and quantitative assessment of residual activity in delivery apparatus after radioembolization

Journal of nuclear medicine technology, 2020-12

2020

Link zum Volltext

Verfügbarkeit prüfen

Modulated DISP3/PTCHD2 expression influences neural stem cell fate decisions

Scientific reports, 2017-01, Vol.7 (1), p.41597-41597, Article 41597

2017

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Mitochondrial STAT3 Supports Ras-Dependent Oncogenic Transformation

Over-expression of DSCR1 protects against post-ischemic neuronal injury

SP-014 - 18F labelled albumin binding synthons enabling PET imaging and enhanced target accumulation of biomolecules

18F labelled albumin binding synthons enabling PET imaging and enhanced target accumulation of biomolecules

Mitochondrial STAT3 Supports RasDependent Oncogenic Transformation

SSP-05 - Next generation therapeutic radiopharmaceuticals targeting cholecystokinin-2 receptor positive cancers

Next generation therapeutic radiopharmaceuticals targeting cholecystokinin-2 receptor positive cancers

The Next Generation of Tumour Homing Peptides: Foldamers at the Forefront of Precise Cancer Theranostics

SP-128 - Structure-activity relationship study of peptide Gastramide-01 (GA-01), a potent binder of cholecystokinin-2 (CCK-2) receptor and theranostic candidate

Foldamers afford improved theranostics targeting cholecystokinin-2 receptor positive cancers

Structure-activity relationship study of peptide Gastramide-01 (GA-01), a potent binder of cholecystokinin-2 (CCK-2) receptor and theranostic candidate

SSP-06 - Foldamers afford improved theranostics targeting cholecystokinin-2 receptor positive cancers

Indirect Lung Absorbed Dose Verification by 90 Y PET/CT and Complete Lung Protection by Hepatic Vein Balloon Occlusion: Proof of Concept

Development of Highly Potent Clinical Candidates for Theranostic Applications against Cholecystokinin‑2 Receptor Positive Cancers

A New Turn in Peptide-Based Imaging Agents: Foldamers Afford Improved Theranostics Targeting Cholecystokinin‑2 Receptor-Positive Cancer

90Y PET for Qualitative and Quantitative Assessment of Residual Activity in Delivery Apparatus After Radioembolization

90 Y PET for Qualitative and Quantitative Assessment of Residual Activity in Delivery Apparatus After Radioembolization

Precision peptide theranostics: developing N - to C -terminus optimized theranostics targeting cholecystokinin-2 receptor

Indirect Lung Absorbed Dose Verification by 90Y PET/CT and Complete Lung Protection by Hepatic Vein Balloon Occlusion: Proof of Concept

Indirect lung absorbed dose verification by yttrium-90 PET/CT and complete lung protection by hepatic vein balloon occlusion: proof-of-concept

Investigation of Fluorine-18 Labelled Peptides for Binding to Cholecystokinin-2 Receptors with High Affinity

Over-expression of RCAN1 causes Down syndrome-like hippocampal deficits that alter learning and memory

Correction to: Investigation of Fluorine-18 Labelled Peptides for Binding to Cholecystokinin-2 Receptors with High Affinity

Yttrium-90 positron emission tomography for qualitative and quantitative assessment of residual activity in delivery apparatus after radioembolization

Modulated DISP3/PTCHD2 expression influences neural stem cell fate decisions

Suchergebnisse filtern